We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Serum Assay Evaluated for Celiac Disease Screening

By LabMedica International staff writers
Posted on 07 Jun 2015
Print article
Image: Immunofluorescence pattern of endomysial antibodies produced using serum from a patient with celiac disease on monkey esophagus with a fluorescein isothiocyanate (FITC) conjugate (Photo courtesy of Simon Caulton).
Image: Immunofluorescence pattern of endomysial antibodies produced using serum from a patient with celiac disease on monkey esophagus with a fluorescein isothiocyanate (FITC) conjugate (Photo courtesy of Simon Caulton).
Celiac Disease (CD) is an autoimmune enteropathy triggered by the ingestion of gluten-containing grains in genetically susceptible individuals and it damages the small intestine mucosa leading to villous atrophy, crypt hyperplasia and intraepithelial lymphocytic infiltrate.

Small bowel biopsy is the conventional gold standard for the diagnosis of CD, but greater emphasis is now given to serological assays like anti-tissue Transglutaminase immunoglobulin (Ig) A antibodies (anti-tTGA), anti-Deamidated Gliadin Peptides IgA and IgG antibodies (a-DGP IgA/IgG) and anti-Endomysium IgA antibodies (EMA).

Scientists at the University of Naples Federico II (Italy) selected 730 children aged between six months and four years nominated Group A: 652 non-CD and 78 CD, and 348 children younger than two years nominated Group B: 327 non-CD and 21 CD which were part of Group A. These groups were used to evaluate the agreement between anti-tTGA and a-DGP IgA/IgG by Kappa coefficient and to compare the diagnostic accuracy of anti-tTGA with that of a-DGP IgA/IgG by Receiver Operating Characteristic (ROC) curve analysis.

Sera from the groups were assayed for IgA and IgG antibodies a-DGP and IgA antibodies anti-tTG by enzyme-linked immunosorbent assay (ELISA) test (Delta Biologicals; Rome, Italy). The IgA antibodies anti-Endomysium were detected by Delta Biological’s Indirect Immunofluorescence (IFI) assay using sections of distal monkey esophagus mounted on glass slides at a starting dilution of 1:5, which was considered the threshold for positivity.

There was a substantial agreement between anti-tTGA and a-DGP IgA in Group A and an almost perfect agreement in Group B. The strength of agreement between anti-tTGA and a-DGP IgG was moderate in Group A and substantial in Group B. The anti-tTGA was more sensitive and specific than a-DGP IgA/IgG in both groups. The strongest point of the current study was the cutoff values being adjusted for the study population in case of all antibody assays according to Receiver Operator Characteristic (ROC) curve analysis.

The authors concluded that anti-tTGA, because of their high diagnostic accuracy, may be used as initial screening assay for CD in all subjects from six months of age, according to new European Society of Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) Criteria 2012. The study was published on June 15, 2015, in the journal Clinica Chimica Acta.

Related Links:

University of Naples Federico II
Delta Biologicals 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Coagulation Analyzer
CS-2400

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.